RA CAPITAL MANAGEMENT, L.P.
Transaction: 07/16/2026
SELL
Change
-213
Price
$19.75
Filing
07/21/2026
Type
SELL
Vor Biopharma Inc.
VOR • Biotechnology
$25.05
▲ +0.81 (+3.34%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.36B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 18.2Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:09 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$25.05
Change3.34%
Shares Out54.30M
Market Cap$1.36B
Enterprise Value$897.07M
52W Range6.50 - 50.20
Beta1.72
P/E2.17
P/B-6.79
P/FCF-9.64
EV/EBITDA-0.96
EV/FCF-6.36
Price$25.05
Change3.34%
Shares Out54.30M
Market Cap$1.36B
Enterprise Value$897.07M
52W Range6.50 - 50.20
Beta1.72
P/E2.17
P/B-6.79
P/FCF-9.64
EV/EBITDA-0.96
EV/FCF-6.36
Earnings Yield46.15%
FCF Yield-10.37%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq-0.02
Current Ratio18.20
Quick Ratio18.20
Target$29.00
Target Upside15.77%
Target Median$29.00
Target Range27.00 - 31.00
Volume975.43K
Avg Volume1.17M
EPS Surprise0.02
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Healthy liquidity · 18.2Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 13 analyst votes · 2026-09-05
88/100
Bullish
Bullish
10
Hold
3
Bearish
0
Price Target
2026-08-13
Low
$27.00
Mean
$29.00
Median
$29.00
High
$31.00
Insider Transactions
Recent executive and insider activity
⚠ 7 high-volume insider sells detected
RA CAPITAL MANAGEMENT, L.P.
Transaction: 07/16/2026
SELL
Change
-2,100,000
Price
$0.00
Filing
07/21/2026
Type
SELL
ZACCARDELLI DAVID
Transaction: 07/07/2026
BUY
Change
+42,658
Price
$20.10
Filing
07/09/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | SELL | -213 | $19.75 | 07/16/2026 | 07/21/2026 |
| RA CAPITAL MANAGEMENT, L.P. | SELL | -2,100,000 | $0.00 | 07/16/2026 | 07/21/2026 |
| ZACCARDELLI DAVID | BUY | +42,658 | $20.10 | 07/07/2026 | 07/09/2026 |
| ZACCARDELLI DAVID | OTHER | 0 | Not reported | 07/07/2026 | 07/09/2026 |
| Levin Andrew David | BUY | +57,162 | $14.09 | 06/11/2026 | 06/12/2026 |
| Beckman Daniella | BUY | +53,283 | $14.09 | 06/11/2026 | 06/12/2026 |
| Cumbo Alexander | BUY | +56,345 | $14.09 | 06/11/2026 | 06/12/2026 |
| Kalir Erez | BUY | +57,162 | $14.09 | 06/11/2026 | 06/12/2026 |
| Joustra Wouter | BUY | +57,162 | $14.09 | 06/11/2026 | 06/12/2026 |
| Namouni Fouad | BUY | +56,549 | $14.09 | 06/11/2026 | 06/12/2026 |
| Detheux Michel | BUY | +57,162 | $14.09 | 06/11/2026 | 06/12/2026 |
| RA CAPITAL MANAGEMENT, L.P. | BUY | +57,162 | $14.09 | 06/11/2026 | 06/12/2026 |
| RA CAPITAL MANAGEMENT, L.P. | SELL | -165,150 | $15.77 | 04/22/2026 | 04/24/2026 |
| RA CAPITAL MANAGEMENT, L.P. | SELL | -171,963 | $15.77 | 04/20/2026 | 04/21/2026 |
| RA CAPITAL MANAGEMENT, L.P. | SELL | -458,411 | $16.28 | 04/17/2026 | 04/21/2026 |
| RA CAPITAL MANAGEMENT, L.P. | SELL | -53,644 | $16.01 | 04/15/2026 | 04/15/2026 |
| RA CAPITAL MANAGEMENT, L.P. | SELL | -153,735 | $15.97 | 04/14/2026 | 04/15/2026 |
| RA CAPITAL MANAGEMENT, L.P. | SELL | -530,610 | $16.15 | 04/13/2026 | 04/15/2026 |
| RA CAPITAL MANAGEMENT, L.P. | SELL | -828 | $15.75 | 04/10/2026 | 04/10/2026 |
| RA CAPITAL MANAGEMENT, L.P. | SELL | -135,201 | $16.59 | 04/09/2026 | 04/10/2026 |